/PRNewswire/ Invizius Limited ("Invizius"), a biotechnology company developing treatments to suppress unwanted immune responses in haemodialysis, is pleased.
Downing FOUR VCT plc LEI: 21380035MV1VRYEXPR9513 June 2022Sale of Downing Ventures business to Foresight Group – Novation of Investment Management Agreement Downing FOUR VCT plc ,. | June 13, 2022